CIK: 0001802528
Total reported value
$1.4B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 19.69% | — | -0.16% | |
| 2 | NUVL | Nuvalent Inc-a | Stock-Other | 13.56% | -5.57% | EXIT | |
| 3 | IMGNEUR | Immunogen INC | Stock-Other | 11.32% | — | -1.66% | |
| 4 | APGE | Apogee Therapeutics INC | Stock-Other | 7.54% | -9.95% | — | |
| 5 | ✓ | Merus N V | Stock-Other | 5.34% | — | +26.91% | |
| 6 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 5.17% | — | +251.27% | |
| 7 | ARGX | Argenx Se - Adr | Stock-Healthcare | 4.95% | — | +13.90% | |
| 8 | COGT | Cogent Biosciences INC | Stock-Other | 4.17% | -9.04% | — | |
| 9 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 4.06% | — | — | |
| 10 | ELVN | Enliven Therapeutics INC | Stock-Other | 3.50% | +0.90% | +0.32% | |
| 11 | IMVT | Immunovant INC | Stock-Other | 3.46% | — | — | |
| 12 | ✓ | Rayzebio INC | Stock-Other | 3.26% | — | — | |
| 13 | DNTH | Dianthus Therapeutics INC | Stock-Other | 3.17% | +8.68% | — | |
| 14 | VRDN | Viridian Therapeutics INC | Stock-Other | 2.53% | -3.74% | — | |
| 15 | TYRA | Tyra Biosciences INC | Stock-Other | 2.31% | — | -1.67% | |
| 16 | CATBUSD | Astria Therapeutics INC | Stock-Other | 1.71% | — | — | |
| 17 | TRVI | Trevi Therapeutics INC | Stock-Other | 1.35% | — | -0.52% | |
| 18 | 430 | Terns Pharmaceuticals INC | Stock-Other | 1.23% | — | — | |
| 19 | ✓ | Stock-Other | 1.11% | — | -4.02% | ||
| 20 | SYRE | Spyre Therapeutics INC | Stock-Other | 0.56% | +4.62% | — |